Rank #1012AXSM

Axsome Therapeutics, Inc.

$186.18

0.78% (Daily)

Market Cap

$9.39B

Revenue

$561.26M

Rank by MCap

#1012

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Herriot Tabuteau M.D.

Headquarters

New York, NY

Employees

816

About Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reup...